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The oil of Glycine max commonly known as soybean oil has over the 
decades grown popularity for its low cholesterol hence its use within 
the household and commercially for food production has grossly 
increased. This study was aimed to determine the effects of long term 
consumption of soybean oil toxicologically and behaviourally.  
Male albino rats were administered with the vehicle, 5 and 10% oil 
emulsion for 30 days orally. The rats were subjected to behavioural 
tests such as novelty-induced behaviour (NIB), learning and memory 
tests and food intake measurement weekly. At the end of 30 days, rats 
were anesthetized and carefully dissected and blood sample was taken 
and analyzed haematogically and biochemically. The liver sample was 
also taken for biochemical analysis. Histopathological examinations 
were carried out on the brain, spleen, liver, kidney, lungs and testis 
samples.  
The results showed that oral administration of oil caused an increase in 
food intake, significant effect on NIB but had no effect on learning and 
memory. There was a significant (p<0.05) reduction in the level of both 
haemoglobin and PCV in the grouped administered with high dose. 
Biochemical analysis revealed a significant (p<0.05) increase in 
triglyceride, ALT, AST levels, with no effect on cholesterol. 
Histopathological analysis revealed no significant effects on the 
essential organs tested when compared with the vehicle treated rats.  
This study conclusively showed that soybean oil has central excitatory 
effects and there is need for caution when used for a long period since it 
has significant effects on biochemical parameters.  




Glycine max (L.) Merr., Leguminosae (Fabaceae)  
is a legume, native to China, that has become a 
major source of vegetable protein and oil for 
human and animal consumption and for industrial 
usage. The valued portion of the plant is the seed, 
which contains about 40% protein and 21% oil. 
So important is the soyabean to the Chinese that 
it is considered one of the five sacred grains 
("Wu Ku") along with rice, wheat, barley and 
millet. The soya bean is also called soy bean, 
soja, soi, soy pea and Manchurian bean. 
Synonyms of soyabean include; Soja japonica 
Savi in Pisa Nuov., Glycine hispida (Moench) 
Maxim., Soja max (L.) Piper Glycine gracilis 
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Glycine max is cultivated and grown traditionally 
in East, South-East and South Asia. Nowadays, it 
is also grown in many countries of the sub-
tropical to warm-temperate zones in most 
continents (North and South America, Asia, 
South-East Europe, Africa-mainly in the East). 
The composition of soyabean: Protein (40%); oil 
(20%); Cellulose and Hemicellulose (17%); 
Sugars (7%); Crude fiber (5%) and ash (dry 
weight basis) (6%) [7]. 
 
The old Chinese herbals suggest that the 
soyabean was a specific remedy for the proper 
functioning of the bowels, heart, kidney, liver, 
and stomach. Commercial grades of natural 
lecithin, often derived from soybean, are reported 
to contain a potent vasodepressor. Medicinally, 
lecithin is indicated as a lipotropic agent. 
Soybean is listed as a major starting material for 
stigmasterol, once known as an antistiffness 
factor. Sitosterol, also a soy byproduct, has been 
used to replace diosgenin in some 
antihypertensive drugs [5]. 
 
Soyabean is a source of complete protein. Soy 
products are also a good source of iron and 
contain vitamins B1 and B2 and an essential oil-
linoleic acid, one of the Omega-3 fatty acids. 
Soyabeans also contains isoflavones which have 
been suggested to help prevent cancers and heart 
diseases. Because soyabean is inexpensive and 
nutrition-packed, it is used to produce a wide 
variety of products including kecap, miso, natto, 
okara, tamari, tempeh, tofu and  yuba which are 
mostly eaten in South Asia. Others include meat 
analogs, soybean oil, soy cheese, soy flour, soy 
ice cream, soy margarine, soy mayonnaise, 
soymilk, soy nuts, soy sauce, soy sour cream, soy 
yogurt, chocolates, biscuits etc.                                                                                                                                         
 
Previous reports showed that adding soy protein 
to the diet can moderately decrease blood levels 
of total cholesterol and low-density lipoprotein 
("bad" cholesterol) while high-density lipoprotein 
("good" cholesterol) does not seem to be 
significantly altered. Some scientists have 
proposed that specific components of soybean, 
such as the isoflavones, genistein and daidzein, 
may be responsible for the cholesterol-lowering 
properties of soy. This may reduce the incidence 
of cardiovascular diseases e.g. myocardial 
infarction.  Omega-3 fatty acids, such as linolenic 
acid, are special fat components that benefit 
many body functions e.g., they inhibit blood 
clotting. Soybean oil is one of the only common 
vegetable oils that contain a significant amount of 
omega-3s. Soyabean oil is the fixed oil derived 
from the seeds of Glycine max (L.) Merr. 
Leguminosae after it has been refined, deodorized 
and clarified by filtration at about 00C [8]. 
Soyabean oil is the dominant vegetable oil used 
domestically in edible oil products. Almost all 
margarines and shortenings contain soyabean oil. 
It is also found in mayonnaise, salad creams, 
frozen foods, chocolates, biscuits, etc. The 
reported chemical constituents of soybean oil are 
as follows: polyunsaturated fatty acids which 
include 44-62% linoleic acid, 19-30% oleic acid, 
and 4-11% linolenic acid. 7-14% palmitic acid 
and 1.4-5.5% stearic acid constitutes the saturated 
fatty acid content of soybean oil [7].  However, 
other studies showed that there are some 
problems with soyabean oil. Nunes et al. [14] 
found that wistar rats treated with soyabean oil 
presented insulin resistance and defective islet 
insulin secretion when compared with untreated 
wistar rats. Ima-Nirwana et al. [10] found that 
repeated heating of soyoil destroyed the 
tocopherols causing raised serum interleukin 6 
and osteocalcin levels leading to increased bone 
resorption and osteoporosis in the long term. 
Rueda-Clausen et al. [16] reported that soybean, 
olive and palm oil oils, fresh and deep fried 
produced an increase in triglyceride plasma levels 
in healthy subjects. A study carried out by Lin et 
al. [12] among Taiwan women showed that there 
is a possible relationship between the high levels 
of ethylene oxide emitted during frying of food 
using soyabean oil and the high incidence of lung 
cancer in Taiwanese women engaged in 
traditional cooking. In a previous research, it was 
observed that soyabean oil emulsion decreased 
lymphocyte proliferation and provoked 
neutrophil and lymphocyte apoptosis and 
necrosis, therefore enhanced the susceptibility of 




the patients to infections [3]. Zhao et al. [18] 
found out that a soy diet (20% soybean protein 
and 5% soybean oil) significantly exacerbates the 
clinical course of systemic lupus erythematosus 
(autoimmune disease) in patients. Therefore, the 
aims and objectives of this study are to 
investigate the central nervous system effects, 
haematological, biochemical and 
histopathological potentials toxicity of sub-
chronic oral administration of soyabean oil 
emulsion in rats. 
 
Materials and Methods 
Reagents 
Absolute ethanol (BDH), Formal saline solution 
10%, Anaesthetic ether (Pharmadrug), Sodium 
hydroxide pellets (BDH), 0.25 M sucrose, normal 
saline and lactate dehydrogenase,  cholesterol 
triglyceride, aspartate transaminase (AST), 
alanine transaminase (ALT),  assay kits by 
RANDOX® (RANDOX laboratories Ltd., 
Autrium UK) and reagents for protein assay. 
 
Animals  
Seventeen albino rats weighing between 101.5 ± 
6.2 g were procured from the Animal House of 
National Agency for Food and Drug 
Administration and Control (NAFDAC), Yaba, 
Lagos, Nigeria. They were transferred to the 
animal house of the Department of 
Pharmacology, Faculty of Pharmacy, OAU, Ile-
Ife and allowed to acclimatize to the new 
environment for a week. All the animals were 
kept under standardized environmental conditions 
and had free access to food and water ad libitum. 
All behavioral tests were carried out between 
9:00 and 16:00 h. All experiments were carried 
out in accordance with NIH guideline for the care 
and use of laboratory animals. 
 
Preparation and administration of soyabean 
oil 
The emulsifiers, Span 80 and Tween 80 at a total 
blend of 1%w/v were used for soyabean oil 
emulsion. The 50 ml emulsion was prepared 
using the bottle method. The required amount of 
span 80 was dissolved in the soyabean oil making 
up the oil phase. Also the required amount of 
Tween 80 was dissolved in distilled water making 
up the aqueous phase. The oil phase was added in 
portions to the aqueous phase in a 200 ml screw 
cap bottle and shaken vigorously after each 
addition. The emulsion formed was then passed 
three times through a laboratory hand 
homogenizer. The 5% and 10%v/v soyabean oil 
are equivalent to 250 and 500 mg/kg dose level 
respectively.  
 
Animals were divided into three groups (Vehicle, 
250 and 500 mg/kg) and were administered 
soyabean oil or vehicle for 30 days. The 
behavioural study was carried out at the end of 
each week. The drug was administered as a 5% 
soy oil emulsion (250 mg/kg), low dose and 10% 
soy oil emulsion (500 mg/kg), high dose. Each 
animal received the drug via the oral route with 
the aid of a stainless steel ball-tipped gavage 
needle attached to a 1 ml syringe. The control 
animals received a placebo containing only 1% 
Tween solution 80 at 5 µl/kg. The first day of 
administration was considered Day 1 of the 
study. The animals were administered drugs or 
vehicle at 8:00 h every day for 30 days. After 
administration, the animals were observed 
immediately for any signs of toxicity and an hour 
later behaviourally. Animals were monitored 
during the study for mortality, clinical signs and 
body weight. At the end of every week 
behavioural (Novelty-induced behaviour test and 
spatial working memory test (Y-maze model)] 
studies were carried out in rats. At the end of the 
30 days, the animals were anesthetized and 
carefully dissected. The blood used in this study 
was obtained using cardiac puncture technique. 
The blood was transferred into heparinized 
bottles, gently rolled to enable the blood mix 
thoroughly with heparin to prevent coagulation. 
Biochemical analysis was carried out on the 
blood alongside with samples of the liver 
obtained from each animal. Samples of the brain, 
spleen, liver, kidney, lung and testis were also 
obtained and preserved in 10% neutral buffered 
formalin for histopathological examination. 
 
 






Novelty-induced behaviour (Open field test) 
The structure used consisted of a square shaped 
area composed of a white painted box (60 x 60 x 
64 cm) with a sheet of glass making up the front 
panel. The floor was divided by permanent red 
markers into nine squares of (20 x 20 cm). An 
hour after administration of the test sample, the 
rats were introduced into the box and total 
locomotion (number of floor units entered; 
crossed with all the paws), the frequency of 
grooming (the number of body cleaning with 
paws, picking of the body and pubis with mouth 
and face washing actions) and the frequency of 
rearing (number of times the animal stood on its 
hind limbs or with the forearm against the wall of 
the observation box or in free air. These 
behavioural states: locomotion, grooming and 
rearing were observed and scored weekly for 10 
min. Before each session, the rats were allowed 
to acclimatize to the testing environment (a quiet 
and well ventilated room) for 30 min before the 
actual test began. Before introducing each 
animal, the wooden box was cleaned with 5% 
ethanol to eliminate possible bias due to the 
odour left by the previous animal. 
 
Learning and memory test (Y-MAZE) 
Spontaneous alternation performance was 
assessed using a wooden Y-maze composed of 3 
equally spaced arms (50 x 10 x 40 cm). The total 
height of the apparatus was 90 cm from the 
ground. This test was done to assess memory 
using spontaneous alternation performance and 
locomotor activity. One hour after the 
administration of vehicle (control) and the test 
samples (250 and 500 mg/kg soyabean oil), each 
rat was placed in one of the arm compartments 
and was allowed to move freely for 6 min. An 
arm entry is defined as the body of a rat except 
for its tail completely entering into an arm 
compartment. The sequence of arm entries is 
manually recorded. An alternation is defined as 
an entry into all three arms on consecutive 
choices. For instance, each alternation is scored 
following the sequence of arm entries (each arm 
is labelled A, B, or C): ACBCABCACABCA. In 
this example, the rat entered 14 arms, eight of 
which are alternations. The number of maximum 
spontaneous alternations is then the total number 
of arms entered minus 2, and the percent 
alternation is calculated as (actual alternations / 
maximum alternations) x 100. The apparatus is 




Blood and organs collection 
After 30 days, the animals were each 
anaesthetized in the anaesthetizing chamber 
already saturated with anaesthetizing ether. When 
the animals were confirmed completely 
anaesthetized, they were carefully dissected. 
Blood was obtained using cardiac puncture 
technique, transferred into pre-labelled 
heparinised sample bottles, and gently rolled to 
allow the blood to mix thoroughly with the 
anticoagulant. Liver sample was obtained from 
each rat and transferred into another sample 
bottle that was kept in a freezer until needed for 
biochemical assay. The brain, kidney, lung, liver, 
spleen and testis samples were also removed and 
placed into sample bottles containing 10% formal 
saline solution. All the samples collected were 
accurately placed in the pre-labelled sample 
bottles designated for the individual animal. 
 
Haematological analysis 
Packed cell volume determination 
With the aid of capillary tubes, blood samples of 
each animal were collected separately from their 
respective heparinised bottles. The tubes were 
allowed to fill via capillary action. The tubes 
were then placed in the micro haematocrit 
centrifuge and spinned for 15 minutes after which 
the volume of the cellular components were read 
using the micro haematocrit reader calibrated in 
the % of total height of the blood in the tube. 
 
Haemoglobin determination 
This was done using the Sahli method. The 
dilution tube was filled with freshly prepared 
0.1N hydrochloric acid to the mark. 10.20 mm3 of 
the heparinised blood was sucked into the pipette 




and released into the acid in the dilution tube. A 
deep brown solution was formed. Distilled water 
was added drop-wisely with stirring in between 
each drop. The colour of the solution in the tube 
was then compared with that in a standard 
contained in a sealed tube. The volume (A) of the 
solution in the sample tube was taken when the 
colour intensity was a bit darker than that of the 
standard. Distilled water was then added until the 
colour of the fluid was slightly lighter than that in 
the standard solution. The volume (B) of the 
solution at this point was taken. The average of A 
and B was taken and designated Y. The amount 
of haemoglobin was calculated as shown: 
 
Amount of haemoglobin = X x Y   g/dl     
                                            100 
 
where X is 100% haemoglobin 
 
Biochemical Analysis 
Before commencement of biochemical analysis, 
the plasma was separated from the whole blood 
and the liver homogenized. The preparation of 
samples for analysis was as follows: 
 
Collection of plasma  
The heparinised blood samples were centrifuged 
at 3000 G for 10 minutes. The supernatant 
(containing the plasma) was aspirated using a 
1000 µl micropippete and transferred into a 
labelled bottle with a well fitted stopper and kept 
in the freezer until needed.  
 
Preparation of the liver homogenate 
A liver sample was taken out of the freezer, 
blotted out of any blood in it and weighed using 
the electronic balance. It was homogenized using 
an electronic homogenizer (Stir-R) at 1600 rpm. 
A 10% homogenate was prepared in 0.25 M 
sucrose. The homogenates were kept in the 
freezer until needed. The samples (plasma and 
liver homogenates) were used for biochemical 
assay for the determination of aspartate 
transaminase (AST), alanine transaminase (ALT), 
lactate dehydrogenase (LDH) using standard 
methods and kits prepared by RANDOX® 
(RANDOX laboratories Ltd., Autrium UK)  and 
protein concentration was estimated using 
Lowry’s method [13]. Cholesterol and 
triglyceride levels were also determined in 
plasma using the standard methods and kits 
prepared by RANDOX®. The amount of 
glutathione (GSH) in the liver homogenate was 
determined in accordance with the modified 
Ellman method [6].  
 
Histopathological studies 
Tissue biopsies for the brain, kidney, liver, lung 
and testis of each animal were processed with 
automated tissue processor (Shandon Citadel 
2000). Sections were cut at 4 microns with the 
rotary microtome and stained with haematoxylin 
and eosin. Additional thin sections of the kidney 
cut at 3 microns were stained with periodic acid 
(Schiff). Histological sections were examined 
using Leica light microscope. 
 
Statistical analysis 
Mean and standard deviations were calculated for 
all quantitative data. The treated and control 
groups were compared  using analysis of variance 
(ANOVA)  and post hoc tests (Dun) were carried 
out to determine the source of significant main 
effect or interaction. Results are expressed as 





In the first week, there was a dose-dependent 
increase in locomotor activity that was significant 
[f(2,16) = 13.01; p = 0.0001] at high dose 10%V/v 
when compared with the control and the low dose 
treated rats. Similar trend was also observed 
during the second week with a significant [f 
(2,16) = 6.38; P = 0.011] increase at the high 
dose when compared with the control. However, 
by the end of the third and fourth weeks, there 
was an insignificant increase in locomotor 
activity (Fig.1). For the rearing activity, a level of 
significant increase was noted in the treatment 





groups as compared with the control on week 1 [f 
(2,16) = 9.23; p = 0.003] while a non-significant 
increase was observed during the remaining three 
weeks time interval (Fig. 2). There was no 
significant difference observed in grooming 
activity (Fig. 3). In the spontaneous alternation 
performance test using Y-maze, a significant [f 
(2,15) = 8.02; p = 0.005] increase in locomotion 
was also observed in the treatment groups when 
compared with vehicle-treated group (control) 
(Fig.4). However, there was no significant effect 
on working memory due to soyabean oil oral 






























Fig.1: The effects of oral administration of soyabean oil 
emulsion (5 and 10%V/v) on locomotor activity in male 
rats. Values are presented as mean ± S.E.M (n=5-6); 


























Fig. 2: The effects of oral administration of soyabean oil 
emulsions (5 and 10%V/v) on rearing activity in male 
rats. Values are presented as mean ± S.E.M (n=5-6); 




























Fig. 3: The effects of oral administration of soyabean oil 
emulsion (5 and 10%V/v) on grooming activity in male 


















Fig. 4: The effects of oral administration of soyabean oil 
emulsion (5 and 10%V/v) on locomotor activity in male 
rats (n=5-6 per group) (Y-Maze model). Each bar 



















Fig. 5: The effects of oral administration of soyabean oil 
emulsion (5 and 10%V/v) on memory using spontaneous 
alternation performance in male rats. Values are 
presented as mean ± S.E.M (n=5-6). 





After 30 days of treatment, there was a significant 
[f (2,16) = 3.861; p<0.05] decrease in the level of 
haemoglobin at the high dose (Fig. 6), however, 
there was a non-significant [f (2,16) = 2.793; 
p=0.095] decrease on packed cell volume level 


















Fig. 6:  The effects of oral administration of soyabean 
oil emulsion (5 and 10%V/v) on Haemoglobin level. 
Values are presented as mean ± S.E.M (n=5-6). *p<0.05 
















Fig. 7: The effects of oral administration of soyabean oil 
emulsion (5 and 10%V/v) on PCV level. Values are 
presented as mean ± S.E.M (n=5-6). 
 
Biochemical analysis 
No significant change was observed in the 
cholesterol assay (Fig. 8). However, there was a 
significant [f (2,16) = 15.05; p = 0.0001] increase 
in triglyceride level in the high dose group when 
compared with the low dose and control groups  
(Fig. 9). The level of LDH in the plasma was not 
significantly affected (Fig.10a), however, in the 
liver, the level of LDH in the low dose group was 
significantly [f (2,16) = 20.55; p = 0.0001] higher 
than those of the high dose and the control groups  
(Fig.10b). In the alanine transaminase (ALT) 
analysis, the high dose treatment group showed a 
significant [f (2,16) = 19.86; P = 0.0001] increase 
when compared with the control and the low dose 
treatment groups in the plasma (Fig. 11a) and 
showed no significant effect in the liver (Fig. 
11b). Although no significant difference was 
observed in the liver AST (Fig. 12b), however, in 
the plasma there was a significant [f(2,16) = 
15.07; p = 0.000] increase in the level of AST 
with the high dose administration when compared 
with the control and the low dose treatment 
groups (Fig. 12a). For the plasma protein, an 
insignificant increase was observed between the 
control and treated groups (Fig. 13a). In the 
analysis of liver protein, there was a significant [ 
f (2,16) = 10.63; p = 0.002] decrease in the level 
of protein in the low dose group (Fig. 13b). In the 
gluthathione analysis, a significant [f (2,16) = 
8.23; P = 0.004] decrease was observed in the 
high treatment group when compared to the low 













Fig. 8. The effects of oral administration of soyabean oil 
emulsion (5 and 10%V/v) on cholesterol level. Values are 















Fig. 9: The effects of oral administration of soyabean oil 
emulsion (5 and 10%V/v) on triglyceride level. Values 
are presented as mean ± S.E.M (n=5-6); *p<0.05 
compared to the untreated (control) group. 































Fig.10 Bar chart showing the amount of Lactate dehydrogenase (LDH) in the plasma and liver of both soyabean oil 
emulsion (5 and 10%V/v) orally administered rats and untreated rats (control). Values are presented as mean ± S.E.M 



























Fig. 11: The amount of alanine transaminase (ALT) in the plasma and liver of both soyabean oil emulsion (5 and 
10%V/v) orally administered rats and untreated rats (control). Values are presented as mean ± S.E.M (n=5-6); *p<0.05 






























Fig. 12: The amount of aspartate transaminase (AST) in the plasma and liver of both soyabean oil emulsion (5 and 
10%V/v) orally administered rats and untreated rats (control). Values are presented as mean ± S.E.M (n=5-6); *p<0.05 
compared to the control group. 
 































Fig. 13: The concentration of protein in the plasma and liver of both soyabean oil emulsion (5 and 10%V/v) orally 























Fig. 14: Glutathione level in the liver of soyabean oil 
emulsion (5 and 10%V/v) orally administered rats and 
untreated (control) rats. Values are presented as mean ± 





Figure 16 shows the effect of change in body 
weight in the animals every week. In the second 
and third weeks, there was increase in the body 
weight of the low dose (5% soybean oil) and high 
dose (10% soybean oil) treatment groups 
however this was not statistically significant. In 
the fourth week there was a significant [f(2,16) = 
5.28; P = 0.020] increase in the high dose 
treatment group when compared with the control. 
The low dose group however showed an 


























Fig. 15: Effects of soyabean oil emulsion (5 and 10%V/v) 
on body weight in male albino rats. Values are 
presented as mean ± S.E.M (n=5-6); *p<0.05 compared 




In the vehicle treated group, the spleen, liver, 
kidney, brain and testes were essentially normal 
while there was a moderate expansion of the 
interstitium with moderate infiltration by 
lymphocytes in the lungs.  In the low dose group, 
the spleen, liver, kidney, brain and testes were 
essentially normal, however, a moderate 
expansion of the interstitium with moderate 
infiltration by lymphocytes was observed in the 
lungs. In the high dose treatment group, a mild 
expansion of the interstitium with moderate 
infiltration by lymphocytes was observed in the 
lungs, whereas, the spleen, liver, kidney, brain 
and testes were essentially normal (Fig. 16). 






Soyabean oil is used generally by the general 
populace and therefore decided to carry out the 
general central nervous system effect and 
potential toxicity studies acutely and sub-
chronically. There was a significant increase in 
locomotor activity with both doses of soyabean 
oil administered in the first week and this effect 
was more pronounced in the high dose treatment 
group. This trend was the same throughout the 
four weeks period of the experiment, however the 
weekly analysis showed that there was a decrease 
in locomotion from the second to the fourth 
week, which may have resulted from habituation. 
The spontaneous motor activity of rodents 
exposed to a new environment is characterized by 
an initial period of hyperactivity i.e. the 
exploratory period, followed by hypoactivity i.e 
the habituation period [2]. Increase in novelty-
induced rearing is considered a central excitatory 
vertical locomotor behaviour [1,2]. In the first 
week, there was a significant increase in rearing 
in both treatment groups that decreased 
drastically from the second to fourth week. 
However, the same trend of increase was 
observed across the groups i.e. the control and 
treatment groups. This decrease in rearing pattern 
across the time intervals may be as a result of 
habituation as earlier stated. Both locomotion and 
rearing behaviour is known to be mediated via D2 
receptor. Grooming has been primarily regarded 
as a behaviour involved in the care of the body 
surface of rodents. Grooming in rodents is 
associated with the stimulation of the dopamine 
receptors D1 and D5 in the brain [4]. In the 30-day 
experiment, there was no significant variation in 
the grooming pattern of the treated animals even 
though it was non-significantly increase. The 
increase in locomotor and rearing activities of the 
rats suggests that soybean oil is excitatory in 
nature.  
 
Memory is a highly complex process that 
involves several brain structures as well as the 
rate of several neurotransmitters and 
neuropeptides [17]. In the Y-maze test, there was 
no significant effect on spontaneous alternation in 
both treatment groups when compared with 
control. This indicates that soyoil has no effect on 
memory. There was a significant increase in the 
Y-maze locomotion pattern. This correlates with 
the excitatory effect observed in the novelty 
induced behaviour further emphasizing that 
soyabean oil is excitatory in nature. 
 
There was a decrease in the haematocrit level of 
the blood of the rats. The results showed that 
haemoglobin level was significantly decreased at 
the high dose administered. However, there was 
no significant difference on PCV level between 
the test groups and the control. Reimold [15] 
found that the haemoglobin and haematocrit 
levels decreased in soyabean oil treated beagles. 
A reduction in the haematocrit and haemoglobin 
levels indicates anaemia [11]. Therefore high 
levels of soyabean oil in the blood may aggravate 
anaemia or cause anaemia in individuals who 
may be prone to it. 
 
Biochemical Analysis 
The results obtained for cholesterol levels 
indicate no significant difference in the 
cholesterol level in both treatment groups. This 
confirms the claim that soyabean oil does not 
increase the level of cholesterol in the blood. A 
significant increase was observed for the 
triglyceride levels of the high dose group. 
Triglycerides belong to the class of the very low 
density lipoproteins. High level of triglycerides in 
the body is known as hypertriglyceridaemia. 
Hypertriglyceridaemia tends to occur in 
association with a reduced high density 
lipoprotein concentration [11].  There is a 
relatively weak independent link between raised 
concentration of very low density lipoprotein 
particles and risk of cardiovascular disease, 
however, hypertriglyceridaemia can cause a 
greatly increased risk of acute pancreatic and 
retinal vein thrombosis [11]. There was an 
insignificant variation in the level of plasma 
protein in contrast to the liver protein in which 
the low dose produced a significant decrease. The 
liver is the principal site of synthesis of all 
circulating proteins in the plasma apart from 




gamma globulins which are produced in the 
reticuloendothelial system [11]. Reduced level of 
protein in the plasma can be associated with 
hepatotoxicity. Reduction in liver protein may be 
associated with the suppression in the synthesis 
of protein. However, this cannot be justified since 
the high dose group showed no significant 
decrease. 
 
Alanine transaminase (ALT) and aspartane 
transaminase (AST) are enzymes present in 
hepatocytes and they leak into the blood with 
liver cell damage. AST is primarily a 
mitochondrial enzyme in the liver. It is also 
present in the heart muscles, kidney and brain 
hence high serum concentration may not be 
specifically indicative of liver damage. On the 
other end, ALT is a cytosol enzyme and it is 
principally found in the liver hence, it is more 
indicative of damage to hepatocytes. Kumar and 
Clark [11] had reported that liver disease can lead 
to an increase in ALT levels. From the results, 
there was a significant increase in the level of 
ALT and AST in the plasma of animals treated 
with high dose level of soyabean oil indicating 
possible damage to the hepatocytes and to an 
extent some other tissues. No significant variance 
was observed in ALT and AST of the liver. High 
concentration of soybean oil may, therefore, be 
indicated or may cause hepatic damage. 
 
There was an insignificant variance in the level of 
plasma LDH in both low and high dose groups. 
However, in the liver, the low dose group showed 
a significant increase in the LDH value which 
was not reflected in the high dose treated group. 
This may indicate damage to hepatocytes in the 
low dose group but, it cannot be conclusively 
stated that the oil resulted in hepatic damage. 
There was a significant decrease in the 
glutathione level in the high dose treatment 
group. Glutathione (GSH) is the general term for 
glutathione sulphydrl. It is a peptide that occurs 
naturally within the body especially in the liver. It 
is the organ’s most abundant antioxidant enzyme. 
It functions as a substrate for key detoxification 
process in the liver in phase II reactions. GSH has 
been shown to play a crucial role in 
cardiovascular diseases such as stroke, 
artherosclerosis and reperfusion injury. Elevated 
GSH levels help to combat the infirmities of 
ageing such as Alzheimer’s disease, cancers of 
ageing (e.g. prostate cancer). The functions of 
glutathione can be summarised as an antioxidant, 
a detoxifier and an immune system enhancer in 
the body. GSH deficiency accompanies liver 
damage. Also, impaired GSH effectiveness 
increases the risk of developing multifactorial 
illnesses and other infections [9].  From the 
results, high concentrations of soy oil may 
deplete the body of its glutathione stores which 
can imply liver damage. Also depletion of the 
stores can invariably makes the body prone to 
infections and diseases.  
 
Histopathology Analysis 
In all the treated groups,the spleen, liver, kidney, 
brain and testes were essentially normal while 
there was a variation in the lungs. This indicates 
that no significant damage was done to these 
organs. The variation in the lungs can be said to 
be inflammation since there was expansion of the 
interstitium and infiltration of lymphocytes. This 
however, cannot be attributed to the oil since the 
untreated group showed a similar variation. On 
the contrary, the biochemical analysis indicated 
variation in the integrity of the liver. There was 
increase in the markers of tissue damage (ALT, 
AST and GSH), mainly in the liver which was 
not indicated in the histopathology examination 
i.e. the liver in all the treated groups were 
essentially normal. The duration of the 
experiment may not have been sufficient enough 
to show a significant effect on the tissue 
histopathologically.  
 
There was gradual increase in the level of food 
intake of the rats. In the fourth week, there was a 
significant change in weight of animals in the 
high dose group when compared with the control. 
This suggests that increase level of soyabean oil 
in food may stimulate increase in food intake 
which leads to an increase in weight. Increase in 
weight was dose dependent. 






Soyabean oil has excitatory effect centrally and 
its principal effect may be on the receptors that 
are involved in the central stimulatory effects - 
such as dopaminergic and cholinergic systems 
among others.  There was a decrease in the level 
of haemoglobin and packed cell volume of the 
animals in the treated group. However, only the 
level of haemoglobin was significantly reduced. 
This indicates that prolonged use of soy oil may 
result in anaemia if blood producing food 
supplements are not taken. Long term 
consumption of soyabean oil did not increase the 
cholesterol levels which supports the claim of its 
beneficial effects. However, the results showed 
that there was hypertriglyceridaemia that can lead 
to detrimental effects on the body. Increased level 
of ALT and AST in the plasma and also 
decreased level of plasma protein in the treated 
groups are indicative of hepatocyte damage, 
however this was not supported by the 
histopathological analysis of the liver tissue. Also 
increased level of LDH (low dose group) in the 
liver is suggestive of possible liver cell damage. 
Depletion of GSH stores in the body can also be 
associated with long term consumption soy oil. 
No evidence of damage was seen in 
histopathology studies on the liver but 
biochemically, long term consumption of the oil 
may be detrimental to the liver. Long term 
consumption of soy oil may also lead to weight 
gain. 
 
Finally, soyabean oil, while not increasing the 
body cholesterol levels may not be regarded as 
being totally devoid of toxic effects on body 
organs especially the liver. Its ability to reduce 
glutathione levels of the body may be regarded as 
a very high risk factor for the development of 
some diseases especially on prolonged 
consumption. Hence, a chronic study of the 
effects of consumption of soyabean oil should be 
carried out to confirm its long term effects on 
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